Biodesix, Inc. (BDSX)

Biodesix Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	71.32	49.09	38.21	54.51	45.56
Revenue Growth (YoY)	45.30%	28.46%	-29.89%	19.64%	85.55%
Cost of Revenue	15.57	13.01	14.15	30.52	22
Gross Profit	55.75	36.08	24.06	23.99	23.56
Selling, General & Admin	80.45	67.39	61.46	50.52	34.86
Research & Development	9.56	9.99	13.1	12.79	10.82
Operating Expenses	90.01	77.38	74.56	63.31	45.68
Operating Income	-34.26	-41.3	-50.51	-39.32	-22.12
Interest Expense	-8.26	-9.54	-8.07	-4.51	-7.6
Other Non Operating Income (Expenses)	0.07	-1.27	0.19	-0.01	-0.81
EBT Excluding Unusual Items	-42.45	-52.1	-58.39	-43.84	-30.53
Asset Writedown	-0.24	-0.04	-0.08	-	-
Other Unusual Items	-0.25	-	-6.98	0.68	-0.82
Pretax Income	-42.93	-52.15	-65.45	-43.16	-31.35
Net Income	-42.93	-52.15	-65.45	-43.16	-31.35
Net Income to Common	-42.93	-52.15	-65.45	-43.16	-31.35
Shares Outstanding (Basic)	130	82	42	27	5
Shares Outstanding (Diluted)	130	82	42	27	5
Shares Change (YoY)	57.92%	95.03%	53.86%	465.63%	1899.17%
EPS (Basic)	-0.33	-0.64	-1.55	-1.58	-6.48
EPS (Diluted)	-0.33	-0.64	-1.55	-1.58	-6.48
Free Cash Flow	-51.88	-45.79	-48.27	-30.46	-24.06
Free Cash Flow Per Share	-0.40	-0.56	-1.15	-1.11	-4.97
Gross Margin	78.17%	73.50%	62.96%	44.01%	51.71%
Operating Margin	-48.03%	-84.13%	-132.17%	-72.14%	-48.55%
Profit Margin	-60.19%	-106.23%	-171.27%	-79.18%	-68.81%
Free Cash Flow Margin	-72.74%	-93.28%	-126.32%	-55.89%	-52.81%
EBITDA	-28.49	-37.97	-46.91	-36.14	-19.21
EBITDA Margin	-39.94%	-77.35%	-122.76%	-66.31%	-42.17%
D&A For EBITDA	5.77	3.33	3.6	3.18	2.9
EBIT	-34.26	-41.3	-50.51	-39.32	-22.12
EBIT Margin	-48.03%	-84.13%	-132.17%	-72.14%	-48.55%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q